Document Detail


Ocular ischemic syndrome secondary to carotid artery occlusion as a late complication of radiotherapy of nasopharyngeal carcinoma.
MedLine Citation:
PMID:  20736842     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
A 39-year-old Chinese man developed ocular ischemic syndrome (OIS) in both eyes 14 years after radiation therapy for nasopharyngeal squamous cell carcinoma. Digital subtraction angiography disclosed occlusion of common carotid arteries and stenosis of both vertebral arteries. Following stenting of the vertebral arteries, visual function improved and ophthalmoscopic abnormalities of OIS regressed in the right eye. Radiation therapy of the head and neck has a relatively high likelihood of causing vascular stenosis. However, we believe this to be the first reported case of OIS following radiotherapy for nasopharyngeal carcinoma.
Authors:
Yamei Tang; Donghua Luo; Wei Peng; Fengting Huang; Ying Peng
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society     Volume:  30     ISSN:  1536-5166     ISO Abbreviation:  J Neuroophthalmol     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-12-01     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9431308     Medline TA:  J Neuroophthalmol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  315-20     Citation Subset:  IM    
Affiliation:
Department of Neurology, The Second Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, China. yameitang@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pulmonary infections and risk of lung cancer among persons with AIDS.
Next Document:  Parathyroid adenoma and chondrosarcoma after treatment of pediatric Hodgkin disease.